No Detail Found!

Anti-cancer potential of Benzophenone-bis-Schiff bases on human Pancreatic Cancer cell line.

Author(s)
Khalid Mohammed Khan HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan
Huma Rasheed Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan
Bibi Fatima HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan
Muhammad Hayat HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan
Fazal Rahim Department of Chemistry, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan
Hayat Ullah Department of Chemistry, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan
Abdul-Hameed HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan
Muhammad Taha Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA UiTM, Puncak Alam Campus, Bandar Puncak Alam, Selangor D. E. Malaysia; Faculty of Applied Science Universiti Teknologi MARA, 40450 Shah Alam, Malaysia
Affan Tahir Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan
Shahnaz Perveen PCSIR Laboratories Complex, Karachi, Karachi, Pakistan
Abstract
Synthetic benzophenone-bis-Schiff bases (1-17) were evaluated for PC3 cell line inhibition. Most of the compounds showed cytotoxic effects but compounds 4, 8, 14, 16, and 17 were found to be potent. The growth inhibition of PC3 cells was in a concentration-dependent manner when treated with compounds 4, 8, 14, 16 and 17 (Figure-2) after 24 H exposure time. The IC50 values of all five most active compounds were calculated as 4 (IC50 = 24 ± 1.4 µM), 8 (IC50 = 29 ± 1.3 µM), 14 (IC50 = 66 ± 2.8 µM), 16 (IC50 = 28 ± 1.4 µM) and 17 (IC50 = 18 ± 2.8 µM) when compared with standard cisplatin (IC50 = 20 ± 1.1 µM). This study has identified potent anticancer agents.
Publication Details
Page(s) 954-958
DOI DOI not available
Published Journal: Journal of Chemical Society of Pakistan, Volume: 38, Issue: 5, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

90

Views